Generic User Fees: API Manufacturers To Pay Less Than Finished Dose Firms

FDA and industry have agreed to create separate tiers for the charges that active pharmaceutical ingredient manufacturers and finished dosage form manufacturers will pay as part of a generic drug user fee program.